Elevation of brain glucose and polyol-pathway intermediates with accompanying brain-copper deficiency in patients with Alzheimer’s disease: metabolic basis for dementia
Open accessThe DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index.
Abstract
Impairment of brain-glucose uptake and brain-copper regulation occurs in Alzheimer’s disease (AD). Here we sought to further elucidate the processes that cause neurodegeneration in AD by measuring levels of metabolites and metals in brain regions that undergo different degrees of damage. We employed mass spectrometry (MS) to measure metabolites and metals in seven post-mortem brain regions of nine AD patients and nine controls, and plasma-glucose and plasma-copper levels in an ante-mortem case-control study. Glucose, sorbitol and fructose were markedly elevated in all AD brain regions, whereas copper was correspondingly deficient throughout (all P < 0.0001). In the ante-mortem case-control study, by contrast, plasma-glucose and plasma-copper levels did not differ between patients and controls. There were pervasive defects in regulation of glucose and copper in AD brain but no evidence for corresponding systemic abnormalities in plasma. Elevation of brain glucose and deficient brain copper potentially contribute to the pathogenesis of neurodegeneration in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Sperling, R. A., Aisen, P. S., Beckett, L. A., Bennett, D. A., Craft, S., Fagan, A. M., Iwatsubo, T., Jack, C. R., Kaye, J., Montine, T. J., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.003 · Cited by 7,155
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K., Hasegawa, K., Hendrie, H., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,332
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Cited by
Uric Acid and Hypertension: An Update With Recommendations
Sanchez-Lozada, L. G., Rodriguez-Iturbe, B., Kelley, E. E., Nakagawa, T., Madero, M., Feig, D. I., Borghi, C., Piani, F., Cara-Fuentes, G., Bjornstad, P., et al. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa044 · Cited by 196
Regional protein expression in human Alzheimer’s brain correlates with disease severity
Xu, J., Patassini, S., Rustogi, N., Riba-Garcia, I., Hale, B. D., Phillips, A. M., Waldvogel, H., Haines, R., Bradbury, P., Stevens, A., et al. (2019) · Communications Biology · doi:10.1038/s42003-018-0254-9 · Cited by 181
Self-citationAnandhan, A., Jacome, M. S., Lei, S., Hernandez-Franco, P., Pappa, A., Panayiotidis, M. I., Powers, R., & Franco, R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.03.009 · Cited by 162
“For example, in Alzheimer’s disease a disruption in glucose uptake and metabolism is found [59, 145, 341].”
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ejaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 143
Li, D., Zhang, W., Wang, Z., & Zhao, P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00300 · Cited by 146
“Although high concentrations of endogenous copper (Cu) (Pal et al., 2015; Greenough et al., 2016; Xu et al., 2016), zinc (Zn) (Kulikova et al., 2015; Mezentsev et al., 2016), and iron (Fe) (Guo et al., 2015; Peters et al., 2015; Sands et al., 2016; James et al., 2017) have been found in these…”
BackgroundA high-glycemic diet is associated with cerebral amyloid burden in cognitively normal older adults
Taylor, M. K., Sullivan, D. K., Swerdlow, R. H., Vidoni, E. D., Morris, J. K., Mahnken, J. D., & Burns, J. M. (2017) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.162263 · Cited by 330
“For example, a suggested increase in cerebral concentration of sugars in AD brains, inversely related to cerebral copper concentration, has a purported role in cerebral metabolism dysregulation and amyloid aggregation (45, 46).”
BackgroundLittle, K., Llorián‐Salvador, M., Scullion, S., Hernández, C., Simó‐Servat, O., del Marco, À., Bosma, E. K., Vargas-Soria, M., Carranza-Naval, M. J., Bergen, T. V., et al. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.10.008 · Cited by 152
Xu, J., Patassini, S., Begley, P., Church, S., Waldvogel, H. J., Faull, R. L. M., Unwin, R. D., & Cooper, G. J. S. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.015 · Cited by 115
Self-citationDi Domenico, F., Barone, E., Perluigi, M., & Butterfield, D. A. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6759 · Cited by 114
“Reduced glucose utilization due to OS/NS-induced impairment of glycolytic enzymes would be further associated with increased glucose levels, especially in the early phases of AD (260).”
Evidence for widespread, severe brain copper deficiency in Alzheimer's dementia
Xu, J., Church, S. J., Patassini, S., Begley, P., Waldvogel, H. J., Curtis, M. A., Faull, R. L. M., Unwin, R. D., & Cooper, G. J. S. (2017) · Metallomics · doi:10.1039/c7mt00074j · Cited by 111
Self-citationDiet and lifestyle impact the development and progression of Alzheimer’s dementia
Arora, S., Santiago, J. A., Bernstein, M., & Potashkin, J. A. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1213223 · Cited by 113
Healthy brain aging: Interplay between reactive species, inflammation and energy supply
Garaschuk, O., Semchyshyn, H. M., & Lushchak, V. I. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2018.02.003 · Cited by 96
Hariharan, A., Robertson, C. D., Garcia, D. C. G., & Longden, T. A. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111872 · Cited by 99
“In conditions like sporadic Alzheimer’s disease, brain glucose levels and metabolism are profoundly dysregulated, 99–102 and, thus, determining the impact of this on pericyte energy sensing and accompanying blood flow control may yield potential targets for improving clinical outcomes in…”
General Aspects of Metal Ions as Signaling Agents in Health and Disease
Krzywoszyńska, K., Witkowska, D., Świa̧tek-Kozłowska, J., Szebesczyk, A., & Kozłowski, H. (2020) · Biomolecules · doi:10.3390/biom10101417 · Cited by 90
Pericytes and the Control of Blood Flow in Brain and Heart
Longden, T. A., Zhao, G., Hariharan, A., & Lederer, W. J. (2023) · Annual Review of Physiology · doi:10.1146/annurev-physiol-031522-034807 · Cited by 88
Ismail, N., Kureishy, N., Church, S. J., Scholefield, M., Unwin, R. D., Xu, J., Patassini, S., & Cooper, G. J. S. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.11.052 · Cited by 75
Self-citationHuang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh‐Li, H. M. (2021) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-021-03426-8 · Cited by 68
Cerebral Fructose Metabolism as a Potential Mechanism Driving Alzheimer’s Disease
Johnson, R. J., Gómez‐Pinilla, F., Nagel, M. A., Nakagawa, T., Rodríguez‐Iturbe, B., Sánchez‐Lozada, L. G., Tolan, D. R., & Lanaspa, M. A. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.560865 · Cited by 77
“Importantly, there is evidence for endogenous fructose production in Alzheimer’s disease patients, with intracerebral levels of sorbitol and fructose 3–5-fold greater than normal (Xu et al., 2016).”
BackgroundInsulin signaling: An opportunistic target to minify the risk of Alzheimer’s disease
Pardeshi, R., Bolshette, N., Gadhave, K., Ahire, A., Ahmed, S., Cassano, T., Gupta, V. B., & Lahkar, M. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.05.004 · Cited by 65
Ahmad, M. H., Fatima, M., & Mondal, A. C. (2019) · Neuropsychobiology · doi:10.1159/000495521 · Cited by 56
Barone, E., Head, E., Butterfield, D. A., & Perluigi, M. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.508 · Cited by 53
“Reduced glucose utilization due to OS-induced impairment of glycolytic enzymes would be further associated with increased glucose levels as occurs in the early phases of AD [102].”
BackgroundPickart, L., Vasquez-Soltero, J., & Margolina, A. (2017) · Brain Sciences · doi:10.3390/brainsci7020020 · Cited by 51
Scholefield, M., Church, S. J., Xu, J., Patassini, S., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2021) · Metabolites · doi:10.3390/metabo11090569 · Cited by 53
“Common disruptions in multiple metabolic pathways have already been identified in ADD and HD brains, including widespread urea [12–15] and glucose increases [13,16–18], dysregulation of glucose and purine metabolism pathways [13,16,17,19,20], and decreases in the essential nutrient pantothenic acid [21,22], also known…”
BackgroundSelf-citationJohnson, R. J., Tolan, D. R., Bredesen, D. E., Nagel, M. A., Sánchez‐Lozada, L. G., Fini, M. A., Burtis, S., Lanaspa, M. A., & Perlmutter, D. (2023) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2023.01.002 · Cited by 52
Diabetes and Alzheimer’s Disease: Can Elevated Free Copper Predict the Risk of the Disease?
Squitti, R., Mendez, A. J., Simonelli, I., & Ricordi, C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-161033 · Cited by 45
Myelin dysfunction in aging and brain disorders: mechanisms and therapeutic opportunities
Huang, Z., Zhang, Y., Zou, P., Zong, X., & Zhang, Q. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00861-w · Cited by 53
“In addition, metal ions such as copper and iron, which are essential for proper myelin growth, maintenance, and function, have been reported to be dysho-meostatic in the brains of individuals with AD [113, 114].”
Sweet Memories or Not? A Comparative Study on Cognitive Impairment in Diabetes Mellitus
Varghese, S. M., Joy, N., John, A. M., George, G., Chandy, G. M., & Benjamin, A. I. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.822062 · Cited by 50
Kulas, J. A., Franklin, W. F., Smith, N. A., Manocha, G. D., Puig, K. L., Nagamoto-Combs, K., Hendrix, R. D., Taglialatela, G., Barger, S. W., & Combs, C. K. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00279.2018 · Cited by 41
“Glucose hypometabolism in the brain is observed in advanced AD, in animal models of AD, and in Down syndrome patients (44, 64, 67, 86).”
BackgroundAgostini, A., Yuchun, D., Li, B., Kendall, D. A., & Pardon, M.-C. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2019.09.019 · Cited by 41
“Not known Elevated levels in the post-mortem AD brain (121).”
BackgroundMao, Y., Zhang, L., Zhang, C., Qin, L., Liao, X., & Zhao, L. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127692 · Cited by 43
Scholefield, M., Unwin, R. D., & Cooper, G. J. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101152 · Cited by 39
Self-citationDienel, G. A. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15293 · Cited by 41
Redox-Dependent Copper Ion Modulation of Amyloid-β (1-42) Aggregation In Vitro
Sasanian, N., Bernson, D., Horváth, I., Wittung-Stafshede, P. E., & Esbjörner, E. K. (2020) · Biomolecules · doi:10.3390/biom10060924 · Cited by 42
Greco, T., Vespa, P. M., & Prins, M. L. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113289 · Cited by 39
“Increased blood glucose can also initiate the polyol pathway, resulting in increased inflammation that can affect mitochondrial function (Chung et al., 2003; Xu et al., 2016).”
BackgroundNeural mechanisms underlying the role of fructose in overfeeding
Payant, M. A., & Chee, M. J. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.06.034 · Cited by 38
High-Sugar Diet Disrupts Hypothalamic but Not Cerebral Cortex Redox Homeostasis
Żebrowska, E., Chabowski, A., Zalewska, A., & Maciejczyk, M. (2020) · Nutrients · doi:10.3390/nu12103181 · Cited by 34
Zhu, Y., Lobato, A. G., Rebelo, A. P., Canic, T., Ortiz-Vega, N., Tao, X., Syed, S., Yanick, C., Saporta, M., Shy, M. E., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.164954 · Cited by 36
“Impaired polyol metabolism and intracellular polyol accumulation have been implicated in many chronic diseases, including diabetic complications, such as diabetic peripheral neuropathy and retinopathy, and metabolic disorders, such as Galactosemia and PMM2-CDG (26, 27).”
Brain insulin resistance and Alzheimer’s disease: a systematic review
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2024) · Dementia & Neuropsychologia · doi:10.1590/1980-5764-dn-2023-0032 · Cited by 39
Kassab, S., Begley, P., Church, S. J., Rotariu, S. M., Chevalier-Riffard, C., Dowsey, A. W., Phillips, A. M., Zeef, L. A. H., Grayson, B., Neill, J. C., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.08.003 · Cited by 35
“The metabolomic profile of the hippocampus of diabetic rats resembles the pattern of abnormal glucose utilization observed in our previous characterization of PNS tissue (sciatic nerve, dorsal root ganglia, and trigeminal ganglia) of STZ-diabetic rats [22] and interestingly is also similar to studies of post-mortem br…”
ResultSelf-citationDiet, Gut Microbiome, and Cognitive Decline
Ettinger, S. E. (2022) · Current Nutrition Reports · doi:10.1007/s13668-022-00435-y · Cited by 34
Dehydroepiandrosterone (DHEA) and its Sulphate (DHEAS) in Alzheimer’s Disease
Štrac, D. Š., Konjevod, M., Perković, M. N., Tudor, L., Erjavec, G. N., & Pivac, N. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200317092310 · Cited by 31
Gerardo, B., Cabral-Pinto, M., Nogueira, J., Pinto, P., Almeida, A., Pinto, E., Marinho-Reis, P., Diniz, L., Moreira, P., Simões, M., et al. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17176051 · Cited by 27
“Post-mortem case-control studies report a significant decrease of Cu in brain tissues of AD patients [21,22], particularly in region such as the hippocampus, amygdala [23], frontal cortex [24], cerebellum, motor and sensory cortex, cingulate gyrus, temporal gyrus, and entorhinal cortex [25].”
BackgroundDialing in on pharmacological features for a therapeutic antioxidant small molecule
Green, K. N., Pota, K., Tircsó, G., Gogolák, R. A., Kinsinger, O., Davda, C., Blain, K., Brewer, S. M., Gonzalez, P., Johnston, H. M., et al. (2019) · Dalton Transactions · doi:10.1039/c9dt01800j · Cited by 30
Grotto, F. S., & Glaser, V. (2023) · BioMetals · doi:10.1007/s10534-023-00530-9 · Cited by 31
“Moreover, the affected regions in individuals with AD are modified by N(ε)carboxymethyl-lysine (CML), which acts as a metal chelator, altering copper homeostasis (Sasaki et al. 1998; Xu et al. 2016).”
Is carbonyl/AGE/RAGE stress a hallmark of the brain aging?
Semchyshyn, H. M. (2021) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-021-02529-y · Cited by 28
Scholefield, M., Church, S. J., Taylor, G., Knight, D., Unwin, R. D., & Cooper, G. J. S. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00488-y · Cited by 30
Self-citationMaggiore, A., Latina, V., D’Erme, M., Amadoro, G., & Coccurello, R. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102578 · Cited by 25
Scholefield, M., Church, S. J., Xu, J., Robinson, A., Gardiner, N. J., Roncaroli, F., Hooper, N. M., Unwin, R. D., & Cooper, G. J. S. (2020) · Metabolites · doi:10.3390/metabo10110438 · Cited by 23
“Following a previous analysis on the Auckland cohort (Xu et al., 2016a), an investigation of two distinct cohorts from the Manchester and Newcastle brain banks was performed in order to investigate whether findings from different groups would produce similar findings.”
MethodSelf-citationNeurodegeneration in juvenile Iberian pigs with diet-induced nonalcoholic fatty liver disease
Zeltser, N., Meyer, I., Hernandez, G. V., Trahan, M. J., Fanter, R. K., Abo-Ismail, M. K., Glanz, H., Strand, C. R., Burrin, D. G., Frano, M. R. L., et al. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2020 · Cited by 26
Dienel, G. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2611-y · Cited by 21
Elevated hippocampal copper in cases of type 2 diabetes
Philbert, S. A., Schönberger, S. J., Xu, J., Church, S. J., Unwin, R. D., & Cooper, G. J. S. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.104317 · Cited by 23
Self-citationOkda, H. E., Sayed, S. E., Ferreira, R. C. M., Gonçalves, R. C. R., Costa, S. P. G., Raposo, M. M. M., Martínez‐Máñez, R., & Sancenón, F. (2019) · New Journal of Chemistry · doi:10.1039/c9nj00880b · Cited by 22
Johnston, H. M., Pota, K., Barnett, M. M., Kinsinger, O., Braden-Kuhle, P. N., Schwartz, T. M., Hoffer, E., Sadagopan, N. S., Nguyen, N., Yu, Y., et al. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b02932 · Cited by 20
Hawkins, K., & Duchen, M. R. (2019) · World Journal of Stem Cells · doi:10.4252/wjsc.v11.i5.236 · Cited by 18
Do microglia metabolize fructose in Alzheimer’s disease?
Sturno, A. M., Hassell, J. E., Lanaspa, M. A., & Bruce, K. D. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03401-x · Cited by 21
“Interestingly, one control patient had significantly increased concentrations of glucose, sorbitol, and fructose in their brain despite having no clinical manifestation of dementia [89].”
InfluentialBall, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2024) · Scientific Reports · doi:10.1038/s41598-024-62155-3 · Cited by 17
“We confirmed this through literature findings with the keyword search “[metabolite name] and BBB permeability” 94–102 .”
MethodFructose-mediated AGE-RAGE axis: approaches for mild modulation
Semchyshyn, H. M. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1500375 · Cited by 17
Philbert, S. A., Xu, J., Unwin, R. D., Dowsey, A. W., & Cooper, G. J. S. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.02.107 · Cited by 24
Self-citationGao, J., Zhou, N., Lu, M., Wang, Q., Zhao, C., Wang, J., Zhou, M., & Xu, Y. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1047121 · Cited by 13
“There is evidence that threefold to fivefold higher cerebral sorbitol and fructose levels in patients with AD may be related to the production of endogenous Frontiers in Microbiology 10 frontiersin.org fructose (Xu et al., 2016).”
BackgroundA new triazine bearing a pyrazolone group capable of copper, nickel, and zinc chelation
Yepremyan, A., Mehmood, A., Brewer, S. M., Barnett, M. M., Janesko, B. G., Akkaraju, G. R., Simanek, E. E., & Green, K. N. (2018) · RSC Advances · doi:10.1039/c7ra09459k · Cited by 15
Bagheri, S., Saboury, A. A., Haertlé, T., Rongioletti, M. C. A., & Saso, L. (2022) · Inorganics · doi:10.3390/inorganics10010006 · Cited by 15
Fructose: metabolic signal and modern hazard
Johnson, R. J., Lanaspa, M. A., Tolan, D. R., Goncalves, M. D., Softic, S., Stanhope, K. L., Sánchez‐Lozada, L. G., Herman, M. A., & Rabinowitz, J. D. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01506-y · Cited by 14
“Interestingly, fructose and sorbitol levels are elevated in brain tissue or cerebrospinal fluid in multiple sclerosis, cranial hypertension, Alzheimer’s disease, bipolar disease, pregnancy and individuals with brain tumours 105–111 .”
Al-Akl, N. S., Khalifa, O., Ponirakis, G., Parray, A., Ramadan, M., Khan, S., Chandran, M., Ayadathil, R., Elsotouhy, A., Own, A. M., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042247 · Cited by 9
“In investigations of AD patients, elevated glucose, sorbitol, and fructose levels have been observed in AD brain regions compared to controls [48].”
BackgroundTian, A., Yan, Z., Li, H., Zhang, Z., Du, L., Huang, X., Sun, L., & Wu, H. (2024) · Food & Function · doi:10.1039/d4fo00774c · Cited by 8
Erukainure, O. L., Matsabisa, M. G., Salau, V. F., & Islam, M. S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.592981 · Cited by 10
“The continuous activation of these enzymes will lead to glucose accumulation which can serve as metabolite precursors for the hexosamine, polyol, protein kinase C, and AGE pathways which have been linked to the pathogenesis of neurodegenerative diseases (Li et al., 2012; Xu et al., 2016).”
BackgroundMani, R. J., Dogra, N., & Katare, D. P. (2023) · Brain Sciences · doi:10.3390/brainsci13101391 · Cited by 8
“Unveiling the molecular mechanisms behind these observations holds promise for future advances in AD treatment and management.”
BackgroundThe Association of Fructose Metabolism With Anesthesia/Surgery-Induced Lactate Production
Zhang, L., Liu, J., Miao, Z., Zhou, R. J., Wang, H., Li, X., Liu, J., Zhang, J., Yan, J., Xie, Z., et al. (2024) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000007350 · Cited by 9
“15 Additionally, administration of fructose is associated with increased β -amyloid deposition in animal models of Alzheimer’s disease.”
Neurotoxicity of copper and copper nanoparticles
Joshi, A., Farber, K., & Scheiber, I. F. (2021) · Advances in neurotoxicology · doi:10.1016/bs.ant.2020.11.001 · Cited by 7
Comprehensive Review on Neuro-degenerative Type 3 DM
Chandarana, C. V., & Roy, S. D. (2021) · Current Diabetes Reviews · doi:10.2174/1573399818666211213103624 · Cited by 6
Odai, T., Terauchi, M., Suzuki, R., Kato, K., Hirose, A., & Miyasaka, N. (2020) · Food Science & Nutrition · doi:10.1002/fsn3.1740 · Cited by 7
Hariharan, A., Robertson, C. D., Garcia, D. C. G., & Longden, T. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.03.14.484304 · Cited by 6
Wang, Z., Liu, Z., Feng, S., Song, X., Liu, D., Ma, N., Zhang, X., Liu, W., Wang, D. O., Liu, X., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.09.003 · Cited by 7
“Xu et al. 82 suggested that similar phenomena in Alzheimer’s disease (AD) patients might be explained primarily by the likelihood that elevated brain glucose levels precede the downregulation of GLUT expression, together with impairments in glycolysis and the tricarboxylic acid cycle in the brain,…”
Microglial fructose metabolism is essential for glioblastoma growth
Billingham, L. K., DeLay, S. L., Eshac, Y., Chia, T.-Y., Tripathi, S., Olson, I. E., Zilinger, K., Subbiah, J., Wang, Z., Sadagopan, N. S., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2521256123 · Cited by 8
High Fructose Negatively Impacts Proliferation of NSC-34 Motor Neuron Cell Line
Lodha, D., & Subramaniam, J. R. (2022) · Journal of Neurosciences in Rural Practice · doi:10.1055/s-0041-1742120 · Cited by 3
Koerich, S., Silva, F. C., Itinose, A. M., Bellozi, P. M. Q., Sandrini, F., Schneider, S. C. S., & Marek, C. B. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116002 · Cited by 3
Raza, W., Öhman, A., Kanninen, K. M., Jalava, P., Zeng, X., de Crom, T. O. E., Ikram, M. A., & Oudin, A. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1401006 · Cited by 2
“Metabolic profiling, which involves quantifying small molecules in cells, tissues, and biofluids, can be an effective tool for identifying new disease biomarkers and understanding disease mechanisms (8–10).”
BackgroundAnalysis of Link between Brain Insulin Resistance and Alzheimer's Disease: A Systematic ReviewPreprint
Andrade, L. J. D. O., de Oliveira, L. M., Bittencourt, A. M. V., Lourenço, L. G. D. C., & de Oliveira, G. C. M. (2023) · Research Square · doi:10.21203/rs.3.rs-2852332/v1 · Cited by 2
Ball, B. K., Kuhn, M. K., Fleeman, R. M., Proctor, E. A., & Brubaker, D. K. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149819 · Cited by 1
Copper Deficiency and Central Nervous System
Kurup, A. R., & Nair, N. (2022) · International Journal of Zoological Investigations · doi:10.33745/ijzi.2022.v08i0s.022 · Cited by 1
Čuperlović‐Culf, M., Yılmaz, A., Stewart, D. J., Surendra, A., Akyol, S., Vishweswaraiah, S., Shao, X., Alecu, I., Nguyen-Tran, T., McGuinness, B., et al. (2021) · medRxiv · doi:10.1101/2021.10.16.21265003 · Cited by 1
Fructose metabolism is associated with anesthesia/surgery induced lactate productionPreprint
Zhang, L., Liu, J., Miao, Z., Zhou, R. J., Wang, H., Li, X., Liu, J., Zhang, J., Yan, J., & Jiang, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4724665/v1 · Cited by 1
Targeting pathological changes in the gut protects the CNS from neuropathology.
Charpentier, B. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3966
The Development of Metal‐Based Antioxidants as Anticancer Agents
Nilewar, S. S., Afroz, T., Dunn, S., Bosque, N. D., & Green, K. N. (2023) · Wiley eBooks · doi:10.1002/9781119951438.eibc2856 · Cited by 1
Huang, H.-J., Chen, J.-L., Liao, J.-F., Chen, Y.-H., Chieu, M.-W., Ke, Y.-Y., Hsu, C.-C., Tsai, Y.-C., & Hsieh-Li, H. M. (2021) · Figshare · doi:10.6084/m9.figshare.16779829
Chen, Y., Li, F., Junlei, Z., 魏明清, 倪敬年, Li, T., Yao, L., Tian, J., & Shi, J. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71909
Metadata
- Authors
- Xu, J., Begley, P., Church, S. J., Patassini, S., McHarg, S., Kureishy, N., Hollywood, K. A., Waldvogel, H. J., Liu, H., Zhang, S., Lin, W., Herholz, K., Turner, C., Synek, B. J., Curtis, M. A., Rivers-Auty, J., Lawrence, C. B., Kellett, K. A. B., Hooper, N. M., Vardy, E. R. L. C., Wu, D., Unwin, R. D., Faull, R. L. M., Dowsey, A. W., & Cooper, G. J. S.
- Affiliations
- University of Auckland (NZ)
- University of Manchester (GB)
- Auckland City Hospital (NZ)
- Salford Royal NHS Foundation Trust (GB)
- Chinese Academy of Sciences (CN)
- Corresponding author
- Cooper, Garth J. S.
- ORCID
- Xu, Jingshu
- Begley, Paul
- Church, Stephanie J.
- Patassini, Stefano
- McHarg, Selina
- Hollywood, Katherine A.
- Waldvogel, Henry J.
- Zhang, Shaoping
- Herholz, Karl
- Turner, Clinton
- Curtis, Maurice A.
- Lawrence, Catherine B.
- Kellett, Katherine A. B.
- Hooper, Nigel M.
- Vardy, Emma R. L. C.
- Wu, Donghai
- Unwin, Richard D.
- Faull, Richard L. M.
- Dowsey, Andrew W.
- Cooper, Garth J. S.
- Venue
- Scientific Reports
- Published
- 2016-06-09
- Volume
- 6
- Issue
- 1
- Pages
- 27524-27524
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC4899713
- OpenAlex
- W2418667749
- Cited by
- 85
- References
- 88
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 11 · 2020: 15 · 2019: 9 · 2018: 4 · 2017: 6 · 2016: 3
- FWCI
- 5.90
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion, cc-by)
- Explore Bristol Research (submittedVersion, cc-by)
- ResearchSpace (University of Auckland) (submittedVersion, cc-by)
- Funders
- Tertiary Education Commission
- Oakley Mental Health Research Foundation (3627092, 3456030, 3702870, 3701339, 3703253)
- Maurice and Phyllis Paykel Trust (3627036)
- Northwest Regional Development Agency
- Maurice Wilkins Centre for Molecular Biodiscovery
- Greater Manchester Comprehensive Local Research Network
- Manchester Biomedical Research Centre
- Medical Research Council (MR/L010445/1, MR/L023784/2, MR/L011093/2, MR/L011093/1, MR/L011093, MR/L011093/3, MR/L023784/1)
- Health Research Council of New Zealand (3338701)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- Alzheimer's disease, brain glucose metabolism, polyol pathway, sorbitol, fructose, copper regulation, neurodegeneration, dementia pathogenesis, plasma glucose, plasma copper
- MeSH terms
- Aged, Alzheimer Disease, Animals, Blood Glucose, Brain, Copper, Dementia, Female, Fructose, Glucose, Humans, Male, Metals, Mice, Inbred C57BL, Mice, Transgenic, Middle Aged, Polymers, Probability, Sorbitol, Mass Spectrometry, Tissue Distribution, Case-Control Studies, Rats, Wistar, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.